Searched for
ORCHID PHARMACEUTICALS
Orchid Chemicals & Pharmaceuticals Q1 net loss at Rs 47.56 croreThe company had posted a net loss of Rs 60.14 crore for the corresponding period of the previous fiscal, Orchid said in a filing to BSE.- Orchid Chemicals gets USFDA nod for anti-bacterial tabletsThe company has received approval from the United States Food and Drug Administration for its abbreviated new drug application for Gemiflox...
- Orchid Chemicals gets USFDA nod for two generic drugsThe nod was for generic Rivastigmine capsules and Felodipine extended release tablets aimed at treating mild to moderate dementia and hyper...
- Orchid Chemicals June quarter net loss is Rs 54.50 croreOrchid Chemicals & Pharmaceuticals' net loss has widened to Rs 54.50 crore for the quarter ended June 30, 2013.
- Buy Orchid Chemicals with a target of Rs 60: CK NarayanBuy Orchid Chemicals & Pharmaceuticals with a stop loss of Rs 49 and look for a price target of Rs 60.
- Orchid Chemicals oral formulations plant gets USFDA approvalOrchid Chemicals & Pharmaceuticals today said US health regulator has inspected and accepted its oral formulations facility near Chennai.
- Buy Orchid Chemicals & Pharmaceuticals with a target of 122.50: Sandeep WagleOrchid Chemicals & Pharmaceuticals Ltd is a ‘BUY’ call with a target of Rs 122.50 and a stop loss of Rs 112.50.
- Buy Orchid Chemicals & Pharmaceuticals with a target of 117: Prakash GabaOrchid Chemicals & Pharmaceuticals Ltd is a ‘BUY’ call with a target of Rs 117 and a stop loss of Rs 112.
- US based Hospira to buy Orchid's API manufacturing, R&D units in $200 million dealOrchid Chemicals today said it will sell various assets including active pharmaceutical ingredients (API) business and a R&D facility to Ho...
- Sell Orchid Chemicals & Pharmaceuticals with a target of 109: Ashwani GujralOrchid Chemicals & Pharmaceuticals Ltd is a ‘SELL’ call with a target of Rs 109 and a stop loss of Rs 124.
- Orchid Chemicals redeems FCCBs worth $167.64 millionOrchid Chemicals & Pharmaceuticals said it has redeemed outstanding overseas securities worth $167.64 million (over Rs 820 crore) on the du...
- Fire at Orchid Chemicals' Chennai unit; no casualtyOrchid Chemicals & Pharmaceuticals today said a fire broke out at its Chennai-based research subsidiary's facility but no one was injured i...
- Orchid Chemicals net profit at Rs 159 cr; stock downOrchid Chemicals & Pharmaceuticals reported standalone net profit of Rs 159.48 crores for the year ended March 2011 against Rs 331.33 crore...
- Orchid to acquire Karalex PharmaThe Chennai-based, Orchid Chemicals & Pharmaceuticals, today said it has entered into an agreement to acquire US-based Karalex Pharma throu...
- US-based Hospira to buy Orchid Chemicals' injectables biz for $400 mnOrchid Chemicals & Pharmaceuticals to sell its injectables business to the US-based Hospira for around $400 million.
- Orchid gets USFDA nod for injection, gets 6-mth exclusivityPharma firm Orchid Chemicals & Pharmaceuticals today said it has received the US drug regulator's nod for its Piperacillin and Tazobactam i...
- Orchid, Glenmark, Lupin & Aurobindo Pharma get US nod for LevetiracetamOrchid Pharmaceuticals, Glenmark Pharmaceuticals, Lupin and Aurobindo Pharmaceuticals have all received US FDA approval for their abbreviat...
- Orchid Chemicals to develop an anti-coagulant drugOrchid Chemicals and Pharmaceuticals, Chennai based pharmaceuticals, will undertake the development and manufacture of an anti-coagulant dr...
- Ranbaxy deal will have big impact on mid-sized cosThe mega Ranbaxy deal will have a trickle-down impact on mid-sized companies Zenotech Labs and Orchid Pharma in which the Delhi-based numbe...
- Orchid gets MHPRA approval for APIOrchid Chemicals & Pharmaceuticals' has received Medicines and Healthcare products Regulatory Agency (MHRA) approval for its Betalactam Act...
Load More- Orchid Chemicals June quarter net loss is Rs 54.50 crore
